Thought Leader Select announces neurology key opinion leader work for top-20 global pharmaceutical company

The pharmaceutical company chose Thought Leader Select over traditional influence-mapping firms to begin identifying and profiling 200 global KOLs in neurology. Thought Leader Select’s exclusive “deep-profiling” research methodology eclipses more limited approaches that rely on subjective data gleaned from surveys with low statistical efficacy.